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dvances in molecular biology, proteomics
and genetic testing have brought us closer to
personalized health care that can tailor treatments
to an individual patient’s needs. Data gathering
capabilities have greatly surpassed data analysis
techniques, creating a need for more effective
methods to analyze a vast and growing amount of
data.
Bioinformatics, the use of computer science
methods and tools in the life sciences, has
exploded as modern high-throughput methods
have generated a deluge of information, including
sequence data, structural data, chemistry data, assay
results and imaging data. While pharmaceutical and
biotechnology companies have begun to appreciate
the potential benefit of information technology
systems in improving the productivity of drug
discovery and research, several hurdles must be
overcome to fully capitalize on the impact this data
may have on the health care industry.
With the help of more than $3 million in
competitive grants from the National Institutes of
Health (NIH) and the National Science Foundation,
Sorin Draghici, Ph.D. is working to develop new
and effective approaches to analyze these data
and identify impacted gene signaling pathways
in a given condition. Draghici holds joint
appointments as professor in the Department of
Computer Science, College of Engineering; and the
departments of Clinical and Translational Science,
and Obstetrics and Gynecology in the School of
Medicine at Wayne State University. In recent
years, Draghici has developed several bioinformatics
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software tools that utilize mathematical algorithms
to extract relevant intelligence from genomics
data by combining statistical analysis with existing
knowledge about how these pathways work.
Correctly identifying the significantly impacted
gene signaling pathways in a given condition can
lead to better decision-making capabilities for drug
development and personalized health.
According to Draghici, current methods that
aim to bridge the gap between data collection and
data analysis are unsophisticated. “Many if not
all existing methods treat the pathways as simple
sets of genes, and either ignore or underutilize
our current understanding about how the body’s
systems work, as well as the gene expression
values made available by current technologies,” he
said. Draghici has developed bioinformatics tools
that will lead to reliable approaches to identify
the most impacted gene signaling pathway in a
given condition, which ultimately will facilitate
pinpointing the molecular causes of a given disease,
and identifying potential therapies and possible side
effects.
Using a systems biology approach, Draghici’s
approach identifies pathways that are significantly
impacted in any condition, which may be
monitored through high-throughput gene
expression. His more sophisticated algorithms can
also identify relevant signaling cascades that can be
potentially targeted for therapeutic intervention.
Access to these tools by biotechnology and
pharmaceutical companies will increase efficiency in
the drug discovery pipeline and, most importantly,
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reduce development costs of new therapeutics. Such
tools can help organizations make early decisions
on pursuing clinical trials.
The technology has been licensed to Advaita
Corporation, where Draghici serves as chief
executive officer and chief technology officer.
Advaita has received additional funding from the
NIH in the form of a Small Business Technology
Transfer grant.
Draghici’s novel analysis method can identify the
significantly impacted gene regulatory pathways in
a given condition, such as lung cancer, obesity and
diabetes. Classical methods fall short and neglect to
take into consideration the roles the genes play in
each pathway. These classical methods can produce
both false positives, pathways that are reported
as being relevant when in reality they are not, as
well as false negatives, relevant pathways that are
not identified as being significant in the given
condition.
Current analysis methods rely too heavily on the
number of differentially regulated genes that fall on
each pathway, rather than taking into consideration
where each gene is positioned and what each gene
does. Draghici’s method pays close attention to
these aspects and can potentially identify regulatory
pathways that can open the way to new therapeutic
interventions in a large variety of conditions such as
cancer, pre-term labor, obesity and more, ultimately
benefiting millions of people suffering from these
conditions.
“Currently, most patients with health conditions
such as cancer are diagnosed because of a clinical
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About Dr. Sorin Draghici:
Dr. Draghici received a B.Sc. in
computer engineering and an M.Sc.
in computer science – software
engineering from Politehnica University
of Bucharest, Romania, and a Ph.D.
in computer science – artificial
intelligence from University of St. Andrews, United
Kingdom. He joined Wayne State University in 1996. He
was recently appointed the first Robert J. Sokol, M.D.
Endowed Chair in Systems Biology.
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change, such as detecting a malignant tumor,”
said Draghici. “By the time the tumor is found,
treatment can be an uphill battle because of
complex changes including the need to kill tumor
cells that might have already spread. If a physician
could identify a departure from the healthy state
well before the tumor is present, these changes in
cells may possibly be reversed. We aim to identify
qualitative changes in the state of a biological
system, with the ultimate goal of eradicating
diseases not by finding a cure for them, but by
preventing them from ever occurring in the first
place.”
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To learn more, visit:
http://vortex.cs.wayne.edu/Sorin/index.htm
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